With the U.S. closing in on President Joe Biden’s goal of injecting 100 million coronavirus vaccinations weeks ahead of his target date, officials announced on Thursday the nation is now in position to help supply neighbors Canada and Mexico.
The Biden administration announced the outlines of a plan to “loan” vaccines to Canada and Mexico even as the president announced that the U.S. is on the cusp of meeting his 100-day injection goal “way ahead of schedule.”
“I’m proud to announce that tomorrow, 58 days into our administration, we will have met our goal,” Biden said.
PRES. BIDEN: "58 days into our administration, we will have met my goal of administering 100 million shots to our fellow Americans. That's weeks ahead of schedule." pic.twitter.com/GHOsie053R
— Breaking911 (@Breaking911) March 18, 2021
Ahead of Biden’s remarks, the White House announced the U.S. is making plans to send a combined 4 million doses of the AstraZeneca COVID-19 vaccine to Mexico and Canada in its first export of shots.
Press secretary Jen Psaki said the administration was in the process of finalizing efforts to distribute 2.5 million doses to Mexico and 1.5 million to Canada as a “loan.” The details are still being worked out.
“Our first priority remains vaccinating the U.S. population,” Psaki said. But she added that “ensuring our neighbors can contain the virus is a mission critical step, is mission critical to ending the pandemic.”
The AstraZeneca vaccine has not been authorized for use in the U.S. but has been by the World Health Organization. Tens of millions of doses have been stockpiled in the U.S., should they receive emergency use authorization, and that has sparked an international outcry that lifesaving vaccine is being withheld when it could be used elsewhere.
The Biden administration and leaders of other wealthy nations have faced calls from France and some global health advocacy groups to donate a small percentage of vaccine produced in the U.S. and other industrialized nations to poor countries. Biden has also fielded direct requests from Canadian Prime Minister Justin Trudeau and Mexican President Andrés Manuel López Obrador to buy vaccines made in the United States.
Global public health advocates say wealthy nations like the U.S. need to do far more to help stem the spread of the global pandemic. The World Health Organization on Thursday issued a report that fewer than 7 million COVID-19 vaccine doses have been administered in Africa thus far. That’s the equivalent of what the U.S. administers in a matter of days.
From his first days in office, Biden has set clear — and achievable — metrics for U.S. success, whether it be vaccinations or school reopenings, as part of an apparent strategy of underpromising, then overdelivering. Aides believe that exceeding his goals breeds trust in government after the Trump administration’s sometimes-fanciful rhetoric on the virus.
The 100 million dose goal was first announced on Dec. 8, days before the U.S. had even one authorized vaccine for COVID-19, let alone the three that have now received emergency authorization. Still, it was generally seen within reach, if optimistic.
By the time Biden was inaugurated on Jan. 20, the U.S. had already administered 20 million shots at a rate of about 1 million doses per day, bringing complaints at the time that Biden’s goal was not ambitious enough. He quickly revised it upward to 150 million doses in his first 100 days.
Now the U.S. is injecting an average of about 2.2 million doses each day — and the pace of vaccination is likely to dramatically rise later this month in conjunction with an expected surge in supply of the vaccines.
According to data from the Centers for Disease Control and Prevention, injections of 96 million doses have been reported to the agency since Biden’s inauguration, but those reports lag the actual date of administration. Vaccination trend lines pointed to Biden breaking the 100 million mark on Thursday, with the numbers likely to be confirmed by the CDC over the weekend.
The president has moved to speed up deliveries of vaccines from Pfizer, Moderna and Johnson & Johnson, as well as to expand the number of places to get shots and people who can administer them, with a focus on increasing the nation’s capacity to inject doses as supply constraints lift.
The risk in setting too rosy expectations is that an administration might become defined by its failure to meet them, such as in May 2020, when President Donald Trump said the nation had “prevailed” over the virus.
At the time, the country had seen about 80,000 deaths from the virus. This week, the U.S. death toll topped 538,000. Trump’s lax approach and lack of credibility also contributed to poor adherence to public safety rules among the American public.